On this page

Ibuprofen and Pseudoephedrine Hydrochloride

Over-the-counter ANDA Official labelling
Informational index, not medical advice. Content is reproduced from public FDA and NLM data. Always confirm against the manufacturer's current prescribing information. Report adverse events to FDA MedWatch.

Overview

Brand name
Ibuprofen and Pseudoephedrine Hydrochloride
Generic name
Ibuprofen and Pseudoephedrine Hydrochloride
Dosage form
Tablet, Sugar Coated
Route
Oral
Marketing category
ANDA · ANDA
Labeler
Ohm Laboratories Inc.
Product type
Human Otc Drug
DEA schedule
Not scheduled
Active ingredients
2
NDC product codes
3
Packages
4
Data completeness
76% of corroborating sources present

Active ingredients

Source: NDC Directory
Active ingredients and strengths as listed in the NDC Directory.
Ingredient Strength RxCUI Monograph
Ibuprofen 200 mg/1 310965 View
Pseudoephedrine Hydrochloride 30 mg/1 1305603 View

Forms, strengths and routes

Source: NDC Directory
Dosage form
Tablet, Sugar Coated
Route of administration
Oral
Presentations
7

Pharmacologic classes are listed in the class section below.

Pharmacologic class

Source: NDC Directory
Established pharmacologic classes (EPC), mechanisms of action (MoA), chemical structures (CS) and physiologic effects (PE).
Class Type Browse
Adrenergic alpha-Agonists [MoA] MoA All 85 members
Anti-Inflammatory Agents EPC All 251 members
Cyclooxygenase Inhibitors [MoA] MoA All 251 members
Non-Steroidal [CS] CS All 251 members
Nonsteroidal Anti-inflammatory Drug [EPC] EPC All 251 members
alpha-Adrenergic Agonist [EPC] EPC All 85 members

Regulatory status

Source: Drugs@FDANDC Directory
Application number
074567
Application type
ANDA · Abbreviated New Drug Application
Approval date
April 17, 2001
Sponsor
OHM LABS
Products on application
1
Submissions recorded
17
Products approved under application 074567.
Product Trade name Form Strength Ingredient Status TE Flags
074567-001 IBUPROHM COLD AND SINUS TABLET IBUPROFEN; PSEUDOEPHEDRINE HYDROCHLORIDE Discontinued —

Approval history

Source: Drugs@FDA
Most recent submissions on application 074567.
Type No. Action Status Date Review
Supplement 29 Labeling Approved January 9, 2012 —
Supplement 28 Labeling Approved January 9, 2012 —
Supplement 27 Labeling Approved January 9, 2012 —
Supplement 26 Labeling Approved August 18, 2008 —
Supplement 23 Labeling Approved September 27, 2006 —
Supplement 20 Labeling Approved March 22, 2006 —
Supplement 17 Labeling Approved July 19, 2004 —
Supplement 9 Labeling Approved August 13, 2002 —
Supplement 8 Labeling Approved July 17, 2002 —
Supplement 7 Manufacturing (CMC) Approved July 17, 2002 —
Supplement 6 Manufacturing (CMC) Approved July 17, 2002 —
Supplement 5 Manufacturing (CMC) Approved May 17, 2002 —
Supplement 4 Manufacturing (CMC) Approved May 17, 2002 —
Supplement 3 Manufacturing (CMC) Approved January 31, 2002 —
Supplement 1 Manufacturing (CMC) Approved January 28, 2002 —
Supplement 2 Labeling Approved August 29, 2001 —
Original application 1 Approved April 17, 2001 —

Review documents

  • 0 · Original application · July 22, 2005
  • 0 · Original application · April 17, 2001

Prescribing information

Source: openFDA Drug Labeling

Reproduced verbatim from the Structured Product Labeling submitted to the FDA (effective 20250227). This is the manufacturer's labelling text, not a summary and not advice.

HUMAN OTC DRUG · 20250227 HUMAN OTC DRUG · 20241122

Indications and Usage

openFDA Drug Labeling

Uses temporarily relieves these symptoms associated with the common cold or flu: headache fever sinus pressure nasal congestion minor body aches and pains

Active ingredients (in each caplet) Purposes Ibuprofen, USP 200 mg (NSAID) nonsteroidal anti-inflammatory drug Pain reliever/fever reducer Pseudoephedrine HCl, USP 30 mg Nasal decongestant

Dosage and Administration

openFDA Drug Labeling

Directions do not take more than directed the smallest effective dose should be used adults and children 12 years of age and over: take 1 caplet every 4 to 6 hours while symptoms persist. If symptoms do not respond to 1 caplet, 2 caplets may be used. do not use more than 6 caplets in any 24-hour period unless directed by a doctor children under 12 years of age: do not use

Warnings Allergy alert Ibuprofen may cause a severe allergic reaction, especially in people allergic to aspirin. Symptoms may include: hives facial swelling asthma (wheezing) shock skin reddening rash blisters If an allergic reaction occurs, stop use and seek medical help right away. Stomach bleeding warning This product contains an NSAID, which may cause severe stomach bleeding. The chance is higher if you: are age 60 or older have had stomach ulcers or bleeding problems take a blood thinning (anticoagulant) or steroid drug take other drugs containing prescription or nonprescription NSAIDs [aspirin, ibuprofen, naproxen, or others] have 3 or more alcoholic drinks every day while using this product take more or for a longer time than directed Heart attack and stroke warning NSAIDs, except aspirin, increase the risk of heart attack, heart failure, and stroke. These can be fatal. The risk is higher if you use more than directed or for longer than directed. Do not use in children under 12 years of age if you have ever had an allergic reaction to any other pain reliever/fever reducer right before or after heart surgery if you are now taking a prescription monoamine oxidase inhibitor (MAOI) (certain drugs for depression, psychiatric, or emotional conditions, or Parkinson's disease), or for 2 weeks after stopping the MAOI drug. If you do not know if your prescription drug contains an MAOI, ask a doctor or pharmacist before taking this product. Ask a doctor before use if stomach bleeding warning applies to you you have problems or serious side effects from taking pain relievers or fever reducers you have a history of stomach problems, such as heartburn you have high blood pressure, heart disease, liver cirrhosis, kidney disease, asthma, thyroid disease, diabetes, have trouble urinating due to an enlarged prostate gland, or had a stroke you are taking a diuretic Ask a doctor or pharmacist before use if you are under a doctor's care for any serious condition taking any other product that contains pseudoephedrine or any other nasal decongestant taking aspirin for heart attack or stroke, because ibuprofen may decrease this benefit of aspirin taking any other drug When using this product take with food or milk if stomach upset occurs Stop use and ask a doctor if you experience any of the following signs of stomach bleeding: feel faint vomit blood have bloody or black stools have stomach pain that does not get better you have symptoms of heart problems or stroke: chest pain trouble breathing weakness in one part or side of body slurred speech leg swelling fever gets worse or lasts more than 3 days nasal congestion lasts for more than 7 days symptoms continue or get worse redness or swelling is present in the painful area you get nervous, dizzy, or sleepless any new symptoms appear If pregnant or breast-feeding, ask a health professional before use. It is especially important not to use ibuprofen during the last 3 months of pregnancy unless definitely directed to do so by a doctor because it may cause problems in the unborn child or complications during delivery. Keep out of reach of children. In case of overdose, get medical help or contact a Poison Control Center right away. (1-800-222-1222)

Do not use in children under 12 years of age if you have ever had an allergic reaction to any other pain reliever/fever reducer right before or after heart surgery if you are now taking a prescription monoamine oxidase inhibitor (MAOI) (certain drugs for depression, psychiatric, or emotional conditions, or Parkinson's disease), or for 2 weeks after stopping the MAOI drug. If you do not know if your prescription drug contains an MAOI, ask a doctor or pharmacist before taking this product.

Ask a Doctor

openFDA Drug Labeling

Ask a doctor before use if stomach bleeding warning applies to you you have problems or serious side effects from taking pain relievers or fever reducers you have a history of stomach problems, such as heartburn you have high blood pressure, heart disease, liver cirrhosis, kidney disease, asthma, thyroid disease, diabetes, have trouble urinating due to an enlarged prostate gland, or had a stroke you are taking a diuretic

Stop use and ask a doctor if you experience any of the following signs of stomach bleeding: feel faint vomit blood have bloody or black stools have stomach pain that does not get better you have symptoms of heart problems or stroke: chest pain trouble breathing weakness in one part or side of body slurred speech leg swelling fever gets worse or lasts more than 3 days nasal congestion lasts for more than 7 days symptoms continue or get worse redness or swelling is present in the painful area you get nervous, dizzy, or sleepless any new symptoms appear

Active Ingredient

openFDA Drug Labeling

Active ingredients (in each caplet) Purposes Ibuprofen, USP 200 mg (NSAID) nonsteroidal anti-inflammatory drug Pain reliever/fever reducer Pseudoephedrine HCl, USP 30 mg Nasal decongestant

Adverse event reports

Source: openFDA FAERS
283,546
FAERS reports mentioning this drug
as of 2026-09-25T03:42:24+00:00
A report count is not a risk measure. FAERS accepts voluntary and mandatory reports without establishing causation, and reporting is influenced by how widely a drug is used, how long it has been marketed, and media attention. FDA states that reports “do not prove that the drug caused the event”. Compare rates, not totals.

Attributed to this product's most-reported active ingredient: IBUPROFEN. Combination products with more than six active ingredients are not attributed, because a report count summed across a long ingredient list measures the list, not the medicine.

Packaging and NDCs

Source: NDC Directory
Every National Drug Code package associated with this medication. The NDC is the identifier used for dispensing, billing and pharmacovigilance in the United States.
Package NDC Product NDC Labeler Description Marketing start
51660-423-21 51660-423 Ohm Laboratories Inc. 20 TABLET, SUGAR COATED in 1 BLISTER PACK (51660-423-21) October 13, 2001
51660-423-41 51660-423 Ohm Laboratories Inc. 40 TABLET, SUGAR COATED in 1 BLISTER PACK (51660-423-41) October 13, 2001
56062-423-41 56062-423 Publix Super Markets Inc 40 TABLET, SUGAR COATED in 1 BLISTER PACK (56062-423-41) October 13, 2001
62011-0070-1 62011-0070 Strategic Sourcing Services LLC 20 TABLET, SUGAR COATED in 1 BLISTER PACK (62011-0070-1) October 13, 2001
51660-423 51660-423 Ohm Laboratories Inc. — October 13, 2001
56062-423 56062-423 Publix Super Markets Inc — October 13, 2001
62011-0070 62011-0070 Strategic Sourcing Services LLC — October 13, 2001

Sources for this page

Every dataset that contributed a fact to this page.
Dataset Agency Used for
NDC Directory FDA Identity, ingredients, strengths, forms, routes, labelers, packages
Drugs@FDA FDA Application, sponsor, submissions, review documents, marketing status
Drug Labeling FDA / NLM Prescribing information reproduced above
FAERS FDA Adverse event report counts

Generated September 25, 2026 · 11 sections on this page.